NASDAQ: ODTX

Odyssey Therapeutics, Inc.

CIK 0001882782 · Biological Products

Small by assets Assets $229M as of Jun 19, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Want to see a complete report first? Today's free report (CHAR 10-Q) is open in full — no account needed.

10-Q Filed Jun 17, 2026 · Period ending Mar 31, 2026

Odyssey Therapeutics files first 10-Q with $175.7M cash, runway into H2 2028

5 material changes detected. Sign up free to read the summary.

View report

8-K Filed Jun 17, 2026 · Period ending Jun 17, 2026

Summary not yet generated.

Partner

Trade ODTX commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

8-K Filed May 11, 2026 · Period ending May 7, 2026

Summary not yet generated.